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Abstract. The morbidity and mortality of vector-borne diseases is closely linked to exposure of the human host to
vectors. Qualitative and quantitative evaluation of individual exposure to arthropod bites by investigation of the specific
immune response to vector saliva would make it possible to monitor individuals at risk of vectorial transmission of
pathogens. The objective of this study was to evaluate and compare the antibody (IgG) response to saliva from
uninfected Glossina species, vectors, or non-vectors of Trypanosoma brucei gambiense by detecting immunogenic
proteins in humans residing in an area endemic for human African trypanosomiasis in the Democratic Republic of
Congo. Our results suggest that the immunogenic profiles observed seemed specific to the Glossina species (vector or
non-vector species) and to the infectious status of exposed individuals (infected or not infected). This preliminary work
tends to support the feasibility of development of an epidemiologic tool based on this antibody response to salivary
proteins.
INTRODUCTION
The chronic form of sleeping sickness (human African try-
panosomiasis [HAT]) caused by Trypanosoma brucei gambi-
ense is found in western and central Africa and is transmitted
to humans by bites of the Glossina vector (tsetse fly). Among
vector Glossina species, Glossina palpalis, G. tachinoides, and
G. fuscipes are able to transmit T. b. gambiense. This slowly
progressing fatal disease often remains undiagnosed because
of lack of specific symptoms observed during its initial stage,
and the infection is readily confused with other febrile ill-
nesses, especially malaria.1 The World Health Organization
(WHO) has recommended systematic screening of popula-
tions by serologic survey to diagnose infected individuals and
to control HAT transmission.2 In the mid1980s, the incidence
of HAT increased to alarming levels comparable to those of
the early 20th century, particularly in the Democratic Repub-
lic of Congo, and it now represents a major public health
problem.3 This re-emergence can be partly explained by lax-
ity in control and research efforts. In view of this alarming
situation, intensification of active case detection and treat-
ment was initiated by the national control programs of dis-
ease-endemic countries and results seem promising; WHO
recently reported a decrease in the number of new reported
cases.4
The morbidity and mortality of sleeping sickness is closely
linked to transmission of the pathogen by the vector, and is
therefore associated with exposure of the human host to in-
fected Glossina bites. However, the relationship between the
presence of vectors and the prevalence of the disease is com-
plex, and other parameters must be considered when evalu-
ating risk of infection.5,6 This complexity underlines the im-
portance of developing new tools to identify populations ex-
posed to a high risk of transmission and which could enable
optimization of epidemiologic surveillance and identification
of individuals who may benefit from monitoring. Currently,
exposure of populations to the Glossina vector is evaluated by
entomologic methods (e.g., capture by traps), but such meth-
ods cannot evaluate heterogeneous individual exposure.7
During blood feeding, insects inject salivary proteins (sia-
lome), primarily to counteract the host hemostasis response
induced by the bite. The pharmacologic properties of these
proteins, such as platelet aggregation inhibitors, vasodilators,
and inhibitors of blood coagulation, are necessary for blood
feeding.8 Some of these salivary proteins also have immuno-
genic characteristics (immuno-sialome) that enable initiation
of a specific immune response.9 Based on these immune prop-
erties, studies have shown the potential of markers of expo-
sure to vector-borne diseases by evaluation of a specific an-
tibody response to salivary proteins in individuals exposed to
the arthropod vector. The first example of an epidemiologic
indicator was reported in the United States in individuals
infected with Borrelia burgdorferi, the causative agent of
Lyme disease.10 The level of IgG antibody specific for Ixodes
damini tick saliva was higher in individuals at high risk of
developing Lyme disease.11 Moreover, specific IgG1 and
IgG4 isotypes of antibody to Triatoma salivary antigens have
been detected in individuals exposed to Chagas disease and
the level of specific IgG4 of Aedes aegypti saliva might be a
marker of intense exposure to Aedes bites.12–15 It has been
also suggested that immune response to sand fly recombinant
salivary gland protein may be a good marker of vector expo-
sure.16 Recently, it has been shown that children from a ma-
laria-endemic area in Senegal developed a specific IgG re-
sponse to Anopheles gambiae saliva that was positively asso-
ciated with the degree of exposure to vector bites evaluated
by classic entomologic studies.17 In addition, high levels of
IgG antibody to saliva appeared to be a predictive indicator
of malaria morbidity.
Few studies have explored the immunogenic properties of
Glossina saliva in sleeping sickness. Immediate or delayed
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hypersensitivity responses have been observed in humans and
rabbits exposed to tsetse fly bites, suggesting immunogenic
properties of Glossina saliva.18,19 Another study attempted to
identify an epidemiologic indicator of human contact with
Glossina by detection of specific antibody of Glossina salivary
glands in human sera, but the immunologic techniques used
(immunoelectrodiffusion) failed to detect an immunologic re-
sponse.20
The present study represents a new attempt to evaluate the
immune response to tsetse fly bites in human populations in
an area endemic for sleeping sickness. The objective of the
study was to detect immunogenic salivary proteins of Glos-
sina (vector and non-vector species) and to compare the pro-
files of these immunogenic proteins, taking into account the
infectious status of individuals living in an area endemic for
HAT.
MATERIALS AND METHODS
Studied population. The study was conducted using sera
from individuals living in the HAT-endemic area of Band-
undu in the Democratic Republic of Congo.21 The status of 74
individuals included in the study was defined using serologic
(card agglutination trypanosoma tests for T. b .gambiense and
trypanolysis test), parasitologic, and molecular (polymerase
chain reaction) investigations.22,23 Stage diagnosis was carried
out for all sleeping sickness cases (n 19), by counting white
blood cells present in the cerebrospinal fluid (CSF). These
results led to defining three groups of individuals: 1) the ENI
group, which included exposed but non-infected individuals
(n  55) who had no positive test results; 2) the P1 group,
which included exposed and infected patients in the first stage
of the disease (n  7) who had positive test results and < 5
white blood cells/L in CSF; and 3) the P2 group, which
included exposed and infected patients in the second stage of
the disease (n  12) who had positive test results and  5
white blood cells/l in the CSF. A negative control (CHU)
group included individuals (n 16) who were never exposed
to Glossina spp. bites; it included personnel from Lapeyronie
Hospital (Montpellier, France). The study adhered to the
ethical principles defined by the Helsinki Declaration, and
was reviewed and approved by local traditional authorities
and by the local Ethical Committee of the Democratic Re-
public of Congo (Public Health Ministry, 2001). All individu-
als enrolled in this study signed an informed consent form.
Saliva collection. Saliva samples from uninfected male and
female Glossina bred in an insectarium (Unité de Recherche
177, Institut de Recherche pour le Développement) were col-
lected. The tsetse flies were enclosed in a tube by a mosquito
net and the tube was placed above a drop of salivation buffer
(10 mM HEPES, 150 mM NaCl, and 5 mM EDTA, pH 7,2) on
warm slides (37°C).24 After 10 minutes of salivation, the sa-
liva solution was collected, pooled, and stored at −20°C be-
fore use. The saliva of four tsetse flies species was collected:
three vector species of T. b. gambiense: (G. fuscipes fuscipes,
G. tachinoides, and G. palpalis gambiensis) and one non-
vector species of T. b. gambiense (G. morsitans morsitans).
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE). Prior to electrophoresis, salivary proteins
were precipitated. A volume of salivary samples was diluted
with nine volumes of ice-cold (−20°C) 80% ethanol. The mix-
tures were incubated for one hour at −20°C and centrifuged at
13,000 rpm at 4°C for 30 minutes. The supernatants were
removed and 1 mL of ice-cold (−20°C) 70% ethanol was
added. Samples were centrifuged as above for 20 minutes.
The supernatants were removed and the pellets were air-
dried. For one-dimensional gel electrophoresis, pellets were
suspended in a mixture of 5× Laemmli:salivation buffer (1:4).
Based on the evaluation of the protein concentration by bicin-
choninic acid (BCA) test (BCA Protein Assay Kit, Pierce,
Rockford, IL), equal quantities of Glossina salivary proteins
(7 g) were deposited in each well for electrophoresis. Sali-
vary proteins were separated by one-dimensional electropho-
resis on a 4–15% gradient acrylamide gel in Tris-glycine
buffer with SDS (Ready gels Tris-HCl; Bio-Rad Laboratories,
Hercules, CA) according to the manufacturer’s instructions.
Separated proteins were observed by staining with silver ni-
trate solution (Sigma-Aldrich, St. Louis, MO) based on a
modified method of Shevchenko and others.25 Gels were
fixed twice for 30 minutes in 30% ethanol and 5% acetic acid
and then washed four times in MilliQ water. Gels were sen-
sitized for one minute in 0.02% sodium thiosulfate, washed
twice (one minute/wash) with Milli/Q water, incubated in
0.1% silver nitrate containing 0.06% formaldehyde for 45
minutes, and washed with MilliQ water. Proteins were then
visualized in developing solution (0.05% sodium carbonate,
0.06% formaldehyde; Sigma-Aldrich) until a desired level of
staining was achieved, after which development was stopped
with 5% acetic acid.
Immunoblotting. The proteins separated by one-
dimensional electrophoresis were transferred onto a polyvi-
nylidene difluoride membrane (Bio-Rad Laboratories) in
Tris-glycine buffer at 100 mA for one hour and at 300 mA for
one hour. The membrane was then washed three times with
Tris-buffered saline (TBS) and blocked with 5% skim milk in
TBS for one hour. The membrane was washed three times
with TBS containing 0.1% Tween 20 and three times with
TBS, and then equilibrated with 2% skim milk in TBS for 20
minutes. Immunogenic proteins were detected by incubation
of the membrane with human sera (1:150) overnight at 4°C.
Mouse anti-human IgG conjugated to alkaline phosphatase
(Sigma-Aldrich) were added at a dilution of 1:5,000. Before
and after addition of the secondary antibody, the membrane
was washed three times in TBS containing 0.1% Tween 20
and three times with TBS. The membrane was incubated with
5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium
substrate (Sigma-Aldrich) until a desired level of staining was
achieved and digitized by a personal densitometer SI (Amer-
sham Biosciences, Piscataway, NJ).
RESULTS
Glossina sialomes. The profiles of salivary proteins (sia-
lomes) from male and female Glossina, both vector or non-
vector species, are shown in Figure 1. Approximately 15–20
bands with molecular weights of 11–240 kD were observed in
saliva samples of each Glossina species. Saliva of the three
potential vector species of T. b. gambiense (G. fuscipes fusci-
pes, G. tachinoides, and G. palpalis gambiensis) had many
common bands (approximately 24, 27, 33, 37, 39, 54, 60, 70,
100, 110, 130, and 150 kD) with some variations in intensity of
silver staining. Some of these proteins were also detected in
G. morsitans morsitans saliva, but non-vector saliva contained
more proteins with molecular weights of approximately 50–72
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kD when compared with vector species. Low molecular
weight proteins (11–33 kD) were found in the eight saliva
samples, but the intensity of silver staining appeared higher in
G. morsitans morsitans saliva. The protein profile of Glossina
saliva appeared to be species specific, with strong similarities
between vector species and important differences in non-
vector species G. morsitans morsitans. The composition of
saliva appeared similar in females and males for all Glossina
species.
Detection of immunogenic proteins according to Glossina
species. We evaluated the immunogenic profile of Glossina
salivary proteins (immuno-sialome) by immunoblotting with
a pool of sera of exposed but non-infected persons (ENI
group) (Figure 2). An IgG antibody response specific to saliva
samples of each Glossina species was detected and the immu-
nogenic profile appeared to be different according to the
Glossina species.
For each saliva sample, 10–15 bands were detected. Some
bands (37, 39, 54, 60, 70, 95, and > 170 kD) were common to
the four species tested. However, the immunogenic profile of
non-vector saliva was different from that obtained with saliva
of vector species. This difference was closely linked to the
immunogenicity of specific proteins observed only in G. mor-
sitans morsitans saliva (50, 55, 65, and 72 kD; Figure 2). We
also detected a specific band of approximately 42 kD in G.
fuscipes fuscipes saliva (Figure 2). In addition, the intensity of
immunogenic bands differed according to Glossina species.
For example, the double band of approximately 130 kD de-
tected in the saliva of the four species (Figure 1) showed
higher immunogenic characteristics only in G. morsitans mor-
sitans. In addition, we observed a signal that had a staircase
appearance at the low molecular weight range in the vector
species. No relevant differences were observed in the immu-
nogenic profile between male and female saliva for any of the
Glossina species. Thus, immunogenicity of salivary proteins
did not appear to be sex dependent for any Glossina species.
Detection of immunogenic proteins of G. fuscipes fuscipes
saliva according to the trypanic status of exposed individ-
uals. We evaluated the immunogenicity of salivary proteins
during chronic evolution of sleeping sickness by comparing
the immune profiles of G. fuscipes fuscipes saliva between
individual groups (pools of sera) with varying trypanic status:
exposed but non-infected persons (ENI group), infected in-
dividuals (P1 and P2 groups), and negative controls (CHU
group). Results were obtained for saliva from G. fuscipes
fuscipes because this species is the main vector of T. b. gam-
biense in the Democratic Republic of Congo. Figure 3 shows
results for male G. fuscipes fuscipes saliva; similar results for
each group were observed in females and mixed (male plus
female) saliva samples. We observed four major bands (37,
54, 60, and 150 kD) in the three exposed groups regardless of
the HAT status. In addition, four minor bands with low im-
munogenicity (90, 95, 110, and 125 kD) were detected in these
three groups. The infected groups (P1 and P2) showed similar
immunogenic profiles. In contrast, a difference in the immu-
nogenic profiles was detected between infected patients (P1
and P2 groups) and exposed but non-infected individuals
(ENI group). Some salivary proteins (four bands between 37
kD and 42 kD) were immunogenic only in the ENI group.
Surprisingly, weak intensity of three immunogenic proteins
(54, 60, and 150 kD), the major 37-kD band, and the previ-
ously observed staircase signal were observed in the CHU
group.
Analysis of the individual immunogenic profile in G. fusci-
pes fuscipes saliva. We investigated the immunogenic profile
of exposed but non-infected (ENI) and infected (P1) indi-
viduals to mixed G. fuscipes fuscipes saliva (female plus
male). This study was carried out on nine ENI patients (Fig-
ure 4A) who were randomly selected, and on all persons in
the P1 group (n  7; Figure 4B).
The profiles of individuals in the ENI group were hetero-
geneous, which suggested variability in the immunogenicity of
salivary proteins among individuals with the same trypanic
status. The four major immunogenic bands (37, 54, 60, and
FIGURE 1. Protein composition of saliva from uninfected male
() and female () Glossina species. Shown are three vector species
(Glossina palpalis gambiensis [G.pg], G. fuscipes fuscipes [G.ff], G.
tachinoides [G.tachi]) and 1 non-vector species (G. morsitans morsi-
tans [G.mm]) of Trypanosoma brucei gambiense. Saliva were ana-
lyzed by 4–15% gradient one-dimensional sodium dodecyl sulfate–
polyacrylamide gel electrophoresis under non-reducing conditions
and silver staining. Molecular mass markers (MW) are shown on the
left in kilodaltons (kDa).
FIGURE 2. IgG immunogenic profile of salivary proteins in male
() and female () Glossina species in exposed but non-infected
persons. Arrows in gel show immunogenic salivary proteins specific
to G.ff and G.mm species. For definitions of abbreviations, see Figure
1. Molecular mass markers (MW) are shown on the left in kilodaltons
(kDa).
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150 kD) and two minor bands with low immunogenicity (90
and 110 kD) differed in intensity among persons in the ENI
group. In addition, such individual variations were also ob-
served for ENI-specific proteins of approximately 37–42 kD.
In contrast, a similar profile of immunogenic salivary pro-
teins was observed among persons in the P1 group. Most
individuals in this group showed a specific IgG antibody re-
sponse to the four major bands (37, 54, 60, and 150 kD) with
particularly high immunogenicity for three of them (37, 60,
and 150 kD). In addition, this homogeneity of the profile of
P1 individuals was observed with two bands having low im-
munogenicity (70 and 110 kD). Most individual profiles (ENI
and P1) had the previously observed staircase signal at low
molecular weights.
DISCUSSION
In the present study, specific immune responses to salivary
proteins of Glossina were detected in humans residing in an
area endemic for a sleeping sickness. We demonstrated that
the specific antibody response to these immunogenic proteins
was dependent on the Glossina species and the infection sta-
tus of studied individuals.
Previous studies on Glossina saliva had been carried out
principally on salivary glands (cDNA bank or protein extrac-
tion) of non-vector Glossina species of T. b. gambiense (G.
morsitans morsitans and G. morsitans centralis), but salivary
glands contain structural proteins that are not secreted during
biting.19 Nevertheless, they enable identification of some pro-
teins with pharmacologic properties involved in inhibition of
the human host hemostasis response.26 In the present study,
the salivation technique used enabled analysis of biologic ma-
terial similar to saliva injected in the vertebrate host during
natural blood feeding. This enabled identification of compo-
nents involved in the host/vector relationship. The sequencing
of an extensive set of expressed sequence tags of the G. mor-
sitans morsitans salivary gland is currently being carried out
and should confirm the effectiveness of our salivation tech-
nique.27
In the present study, analysis of sialomes identified 15–20
bands by one-dimensional SDS-PAGE. It would be useful to
FIGURE 3. IgG immunogenic profile of Glossina fuscipes fuscipes
saliva in three patients groups (ENI, P1, and P2) and to the non-
exposed group (CHU). Arrows shows four major bands and arrow-
heads show four minor bands commonly detected in the three ex-
posed groups. ENI  exposed but non-infected individuals with no
positive results for four tests; P1  exposed and infected patients in
the first stage of the disease who had positive results for four tests;
P2 exposed and infected patients in the second stage of the disease
who had positive results for four tests. Molecular mass markers (MW)
are shown on the left in kilodaltons (kDa).
FIGURE 4. A, Individual IgG immunogenic profile of Glossina
fuscipes fuscipes saliva in nine individuals (A–I) from the exposed but
non-infected group (ENI). B, Individual IgG immunogenic profile of
G. fuscipes fuscipes saliva in seven individuals (−) from the ex-
posed and infected group (P1). Molecular mass markers (MW) are
shown on the left in kilodaltons (kDa).
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determine whether one band corresponds to one or more
proteins. Such identification could be performed by separat-
ing the salivary proteins by two-dimensional electrophoresis
and analyzing them by mass spectrometry. However, we have
shown that numerous bands are common to Glossina species,
but other bands are present only in potential vector species
(G. fuscipes fuscipes, G. tachinoides, and G. palpalis gambi-
ensis) and non-vector species (G. morsitans morsitans) of T. b.
gambiense. This difference in saliva composition, including
the presence or absence of certain salivary proteins, could be
involved in vector capacity of the Glossina species. For ex-
ample, a salivary protein may be essential for continuation of
the parasite maturation cycle in the vector, as suggested in the
Anopheles mosquito.28
To our knowledge, the present study is also the first de-
scription of Glossina immuno-sialome carried out by investi-
gating the specific human IgG response to Glossina saliva in
a population exposed to HAT. Previously, hypersensitivity
reactions of an immediate or delayed type were observed in
humans, but specific salivary components involved had not
been identified.18,20 Moreover, a previous study described sia-
lome and immunogenic salivary proteins of G. morsitans cen-
tralis that were detected by IgG antibodies from sensitized
rabbits.19
Comparison of immuno-sialomes of the four Glossina spe-
cies shows a difference in the profile of immunogenic proteins
according to species. This difference was greater between
Glossina vector species or non-vector species of T. b. gambi-
ense, as we observed in sialome analyses. Most of these im-
munogenic proteins were common to the four Glossina spe-
cies. Nevertheless, the immunoblotting approach distin-
guished immunogenic proteins specific to Glossina species (42
kD specific for G. fuscipes fuscipes and 50, 55, 65, and 72 kD
specific for G. morsitans morsitans). Species-specific antigens
were also identified in Phlebotomus and Aedes species.29,30
The difference in immunogenic protein composition in Glos-
sina species may also be involved in transmission of the para-
site. For example, the immune response induced by specific
proteins of non-vector G. morsitans morsitans (50, 55, 65, and
72 kD) could play a role in preventing infection permissive-
ness. It has been demonstrated that the specific immune re-
sponse to one Phlebotomus salivary antigen (PpSP15) can
confer protection against the development of leishmaniasis in
animal models.31
Another difference between vector and non-vector Glos-
sina species was also observed. A signal (< 37 kD) in the form
of bands in a staircase pattern was only detected in saliva of
Glossina vector species (G. fuscipes fuscipes, G. tachinoides,
and G. palpalis gambiensis). One hypothesis is that this signal
could be an artifact of handling. In addition, endosymbiont
Sodalis glossinidus bacteria can be found at the level of sali-
vary glands of certain Glossina species, but are absent in G.
morsitans morsitans salivary glands.32 Another hypothesis is
that proteins of these bacteria are secreted during Glossina
bites and induce a specific immune response in humans. The
staircase signal was also detected in G. fuscipes fuscipes saliva
using sera from the CHU group, which was not exposed to
Glossina bites and thus was not exposed to S. glossinidus. This
surprising result may also represent the same artifact of han-
dling or detection of cross-reactivity with compounds of other
bacteria. Moreover, numerous bacteria express proteins on
their surface that bind to the Fc regions of IgG, which will
enable these bacteria to be covered with host protein and
escape the defense mechanism of the host.33 Some bands ob-
served in the presented immunoblottings might be linked to
this bacterial capacity. Such proteins from bacterial surfaces
could be present in Glossina saliva and thus bind IgG anti-
bodies (human antibodies in serum and/or secondary antibod-
ies used in the assay) in a non-specific manner. In addition,
three bands with low immunogenicity (54, 60, and 150 kD)
were detected with the sera of the CHU group, which also
suggests immune cross-reactivity. This could be due to cross-
reactions between common epitopes of arthropod salivary
proteins from mosquitoes, horseflies, and sand flies. Further
investigations are necessary to define the immunologic speci-
ficity of salivary proteins of Glossina.
We also studied the relationship of immuno-sialome to the
specific immunogenic profile relative to the trypanic status of
individuals (exposed but non-infected [ENI] and infected [P1
and P2]). We investigated the specific immune response to G.
fuscipes fuscipes because this species is the main vector spe-
cies of T. b. gambiense in the Democratic Republic of Congo.
Immunoblotting with a pool of sera from these three groups
resulted in detection of immunogenic proteins that were clas-
sified into two clusters according to their intensity of immu-
nogenicity: the four major bands with high immunogenicity
(37, 54, 60, and 150 kD) and four minor bands with low im-
munogenicity (90, 95, 110, and 125 kD). We observed a simi-
lar immunologic profile for these two clusters in the three
exposed groups. This resulted in detection of common sali-
vary proteins that are immunogenic in all groups exposed to
G. fuscipes fuscipes bites regardless of the infection status of
the patients. However, some variations in detection of immu-
nogenic proteins were observed between the ENI and P1/P2
groups. The IgG response to smaller salivary proteins (four
bands between 37 kD and 42 kD) was detected only in the
ENI group. This suggests that the immunogenicity of some
salivary proteins decreases with the infection status of sleep-
ing sickness (exposed versus infected), which could be due to
immunosuppression observed during development of sleep-
ing sickness.34
Analysis of the immunologic profile of exposed (ENI
group) and infected (P1 group) individuals also confirmed
group-dependent differences according to the exposed versus
infected status. The ENI group showed heterogeneity in im-
munogenic profiles between individuals, which suggested that
exposed but non-infected individuals have a different immune
response to Glossina salivary proteins. In contrast, the immu-
nogenic profile was similar among infected P1 individuals for
whom three major bands (37, 60, and 150 kD) with high im-
munogenicity were commonly detected.
Since the mid 1990s, several studies have investigated the
immune response of mammalian hosts to arthropod bites.35
Qualitative and quantitative evaluation of specific human an-
tibody responses to arthropod salivary proteins may be a use-
ful marker of exposure to vector-borne diseases, similar to
markers for malaria in Senegal and for Chagas disease and
visceral leishmaniasis in Brazil.12,16,17
Selection of immunogenic proteins for elaboration of an
immune marker of exposure to Glossina requires knowledge
of vector saliva composition in proteins (sialome) and immu-
nogenic characteristics of these proteins (immuno-sialome).
Candidate proteins must be expressed in saliva of most Glos-
sina species, or at least be common to vector Glossina species.
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In several hematophagous species, the male does not take a
blood meal, which is reflected in salivary morphology and
secretions.36 Both female and male Glossina could be vectors
of Trypanosoma, and we have shown that both sexes have
similar immunogenic profiles of salivary proteins. Since the
observed immune response must be specific to Glossina sali-
vary antigens, the protein containing potential common
epitopes with other vector arthropods would have to be elimi-
nated from the pool of candidate proteins. Furthermore, im-
munogenic proteins specific to a Glossina species (42 kD for
G. fuscipes fuscipes and 50, 55, 65, and 72 kD for G. morsitans
morsitans in our study) should also be markers of distinguish-
ing specific exposure to the bite of one Glossina species.
Candidate proteins should have immunogenic properties
enabling detection of specific antibodies in all persons ex-
posed to Glossina bites, whether or not the persons are in-
fected. Several immunogenic proteins of interest were em-
phasized in our results. Major proteins were identified in ENI
and P1 individuals, including 37-, 60-, and 150-kD bands.
However, these bands, except for the 37-kD band, also ap-
peared to be immunogenic in the unexposed CHU group but
their immunogenicity was low. Among the minor proteins,
only the 110-kD protein was immunogenic in most individuals
exposed to Glossina bites, but it showed weak immunogenic-
ity in our study. We have not identified a marker protein, and
our results represent a first attempt to characterize the im-
munogenic profile of Glossina salivary proteins in an exposed
population. Nevertheless, this study indicates the feasibility of
elaboration of an immuno-epidemiologic marker of exposure
based on antibody response to salivary proteins.
Further studies on other sleeping sickness transmission foci
are needed to confirm these results. The immuno-proteomic
approach using two-dimensional electrophoresis could iden-
tify immunogenic proteins specific for exposure to Glossina
bites and could be used for mass spectrometric characteriza-
tion of proteins. After immunogenic proteins are identified,
selected proteins could be produced in their recombinant
form and a quantitative method (enzyme-linked immunosor-
bent assay) could be used to evaluate specific individual an-
tibody titers to these proteins in the framework of large-scale
immuno-epidemiologic studies. These immunologic results
could be compared with exposure (as evaluated by an ento-
mologic approach) and morbidity data.
The development of an immuno-epidemiologic marker of
exposure to Glossina bites could represent a tool complemen-
tary to those currently available, which include diagnostic
tests enabling evaluation of morbidity and environmental
data (satellite data, climate models, entomologic information,
and cartography) that define where and when populations
have been exposed to vectors and parasites.37 Such a marker
could be used to estimate the exposure of individuals to Glos-
sina bites and be an indicator of risks of HAT transmission.
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